A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease
Clinical trial NCT05015127 · UNKNOWN
Trial details
- NCT number
- NCT05015127
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2022-10-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.